1.500
+0,00%
2026-10-16
Fundamental Analysis
11 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +14.5% | -173.1% | 1 / 3 | -11.0% | -5.84 pp | -0.80 pp | -14.6% | 1.92 | — | 468 | −11,0% | −12,8 | −26,2% | — | 13.79 | — |
| Pts | 0 | 0 | 4 | 0 | 0 | 4 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 1.500 (close price on 2026-10-16)EPS (TTM): −49,6
Financial charts
1.Revenue & growth
VND bn468Q2/26
1.Revenue & growth
VND bn468Q2/26
2.Profit & growth
VND bn-14,4Q2/26
3.Profit mix (Penman)
VND bn-8,18Q2/26
4.Margins & cost structure
%5.0%Q2/26
5.Returns & cash cycle
% · days-7.9%Q2/26
6.Earnings quality & cash
VND bn-116Q2/26
7.Asset structure
VND bn6.094Q2/26
8.Funding & debt health
VND bn · times6.094Q2/26
9.Revenue backlog
VND bn446Q2/26
10.Valuation
times · %-30,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-36Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-267%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26